OrthoPediatrics (NASDAQ:KIDS) Sees Unusually-High Trading Volume – Here’s What Happened

OrthoPediatrics Corp. (NASDAQ:KIDS) shares saw unusually-high trading volume on Wednesday. 334,912 shares were traded during mid-day trading, an increase of 89% from the previous session’s volume of 176,969 shares. The stock last traded at $23.5170 and had previously closed at $23.50.

Analyst Ratings Changes

Several research firms have commented on KIDS. Piper Sandler reissued an “overweight” rating and issued a $25.00 price objective (up from $22.00) on shares of OrthoPediatrics in a research report on Wednesday, August 5th. Needham & Company LLC upped their target price on OrthoPediatrics from $30.00 to $35.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Truist Financial upgraded OrthoPediatrics to a “hold” rating in a research note on Thursday, October 1st. Weiss Ratings upgraded OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 5th. Finally, BTIG Research reiterated a “buy” rating and set a $29.00 target price on shares of OrthoPediatrics in a report on Monday, September 14th. Five equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $26.50.

OrthoPediatrics Stock Up 0.3%

The firm’s 50 day moving average price is $23.04 and its two-hundred day moving average price is $20.05. The firm has a market capitalization of $615.41 million, a PE ratio of -14.03 and a beta of 0.99. The company has a quick ratio of 2.17, a current ratio of 4.78 and a debt-to-equity ratio of 0.28.

OrthoPediatrics (NASDAQ:KIDS) last released its quarterly earnings results on Tuesday, August 4th. The company reported ($0.26) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.30) by $0.04. OrthoPediatrics had a negative net margin of 15.72% and a negative return on equity of 8.10%. The firm had revenue of $70.51 million for the quarter, compared to the consensus estimate of $68.21 million. As a group, research analysts forecast that OrthoPediatrics Corp. will post -1.14 EPS for the current fiscal year.

Insider Buying and Selling at OrthoPediatrics

In other news, Director David Pelizzon sold 326,700 shares of the firm’s stock in a transaction dated Friday, August 28th. The stock was sold at an average price of $23.04, for a total transaction of $7,527,168.00. Following the completion of the sale, the director directly owned 6,536,764 shares in the company, valued at $150,607,042.56. This trade represents a 4.76% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder Squadron Capital Llc sold 326,700 shares of OrthoPediatrics stock in a transaction dated Friday, August 28th. The stock was sold at an average price of $23.04, for a total value of $7,527,168.00. Following the sale, the insider directly owned 6,536,764 shares in the company, valued at approximately $150,607,042.56. The trade was a 4.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 2,100,000 shares of company stock valued at $46,747,931 in the last ninety days. Insiders own 32.50% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. GAMMA Investing LLC increased its holdings in OrthoPediatrics by 70.3% during the 3rd quarter. GAMMA Investing LLC now owns 1,165 shares of the company’s stock worth $26,000 after purchasing an additional 481 shares during the last quarter. Legal & General Group Plc acquired a new position in shares of OrthoPediatrics in the 2nd quarter valued at approximately $34,000. Quantinno Capital Management LP acquired a new position in shares of OrthoPediatrics in the 1st quarter valued at approximately $160,000. Waverly Advisors LLC acquired a new position in shares of OrthoPediatrics in the 1st quarter valued at approximately $184,000. Finally, R Squared Ltd acquired a new position in shares of OrthoPediatrics in the 1st quarter valued at approximately $212,000. Hedge funds and other institutional investors own 69.05% of the company’s stock.

OrthoPediatrics Company Profile

OrthoPediatrics Corp. is a medical device company focused exclusively on developing and commercializing orthopedic products for children. Headquartered in Warsaw, Indiana, the company designs implants and instruments intended to address the distinct anatomical and clinical needs of pediatric patients, including those whose bones are still growing.

Its product portfolio includes systems for pediatric trauma and deformity correction, scoliosis treatment, limb reconstruction, and pediatric sports medicine.